comprehensive -WSS

comprehensive

author：hotspot 2025-09-27 13:10:36 - browse：586

Gavel and Stethoscope due process — District courts will make the first round of decisions soon on challenges to Medicare's drug price negotiation program. APStock

WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare to negotiate prescription drug prices, will soon face their first big tests.

District court judges could soon weigh in on the litany of court cases that major companies filed against the government — shedding light on whether drugmakers have any hope of postponing the first parts of the negotiation process, scrapping it entirely, or sending the issue up to the Supreme Court.

It’s a major moment for the Biden administration, too, as the White House ramps up its efforts to take credit for the new changes in the 2024 election. The first round of legal decisions will play out in the thick of campaign season, attorneys told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Why hospitals are withdrawing from US News rankings

entertainment

WSS

Massive project maps cells in human brain in unprecedented detail

A public scorecard can help hold safety

Biden tests positive for Covid

What's changing in Medicare's open enrollment this year?

Group opposing PBM reform sets lobbying record

Google and Epic fight stronger regulation of AI in health care

entertainment

comprehensive

hotspot

At least 13 dead in Texas as scorching temps continue

There’s no way to know how good AI health technologies are

Novavax promises a turnaround & Lilly roils the obesity market

Sanders adds drug shortage policies to pandemic preparedness bill

ChatGPT in medicine: STAT answers readers' burning questions

Eight reasons why you should get an updated Covid vaccine

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Nick Jonas talks about managing diabetes along with his career

Medical records are filled with copy

Akero's treatment for NASH falls short in cirrhosis study

hotspot

Massive project maps cells in human brain in unprecedented detail

Why hospitals are withdrawing from US News rankings

FDA approves RSV monoclonal antibody for infants, toddlers

Life sciences deals on track to hit lowest point since 2017

How doctors and nurses shape Google's AI

Google and Epic fight stronger regulation of AI in health care

focus

explore

entertainment

entertainment